Randomized comparison between 2-link cell design biolimus A9-eluting stent and 3-link cell design everolimus-eluting stent in patients with de novo true coronary bifurcation lesions: the BEGIN trial.
Yamawaki M, Muramatsu T, Ashida K, Kishi K, Morino Y, Kinoshita Y, Fujii T, Noguchi Y, Hosogi S, Kawai K, Hibi K, Shibata Y, Ohira H, Morita Y, Tarutani Y, Toda M, Shimada Y, Ikari Y, Ando J, Hikichi Y, Otsuka Y, Fuku Y, Ito S, Katoh H, Kadota K, Ito Y, Mitsudo K.
Yamawaki M, et al. Among authors: kishi k.
Heart Vessels. 2019 Aug;34(8):1297-1308. doi: 10.1007/s00380-019-01368-3. Epub 2019 Mar 11.
Heart Vessels. 2019.
PMID: 30859377
Clinical Trial.